Zobrazeno 1 - 10
of 93
pro vyhledávání: '"Oncology therapy"'
Publikováno v:
Dermatology and Therapy, Vol 14, Iss 10, Pp 2917-2921 (2024)
Abstract Vorasidenib, an oral dual inhibitor targeting mutant enzymes isocitrate dehydrogenase 1 and 2, is utilized in the management of diffuse low-grade gliomas. Despite limited documentation of its adverse events, we present the case of a 44-year-
Externí odkaz:
https://doaj.org/article/c7bf2ed20bcd4a07948a7bd876243549
Autor:
Natalie R Dickson, Karen D Beauchamp, Toni S Perry, Ashley Roush, Deborah Goldschmidt, Marie Louise Edwards, L Johnetta Blakely
Publikováno v:
Journal of Patient-Reported Outcomes, Vol 8, Iss 1, Pp 1-18 (2024)
Abstract Background Utilization of electronic patient-reported outcome (ePRO) tools to monitor symptoms in patients undergoing cancer treatment has shown clinical benefits. Tennessee Oncology (TO) implemented an ePRO platform in 2019, allowing patien
Externí odkaz:
https://doaj.org/article/1e40fe44afc04f1f9a4f8d21b40f8859
Publikováno v:
Discover Oncology, Vol 14, Iss 1, Pp 1-12 (2023)
Abstract Combination therapies have taken center stage for cancer treatment, however, there is a lack of a comprehensive portrait to quantitatively map the current clinical combination progress. This study aims to capture clinical combination therapi
Externí odkaz:
https://doaj.org/article/87e9745687ae46a2b7ff5f0ae6e0e8dc
Autor:
Hiroaki Sato, Tomokazu Sazuka, Ayumi Fujimoto, Sakurako Kagitani, Takayuki Arai, Yusuke Goto, Yusuke Imamura, Shinichi Sakamoto, Jun‐Ichiro Ikeda, Tomohiko Ichikawa
Publikováno v:
IJU Case Reports, Vol 6, Iss 3, Pp 185-189 (2023)
Introduction Combination therapy using immuno‐oncology drugs with tyrosine kinase inhibitors is increasingly important in the therapeutic strategy for metastatic renal cell carcinomas. Here, we report a case of metastatic renal cell carcinoma that
Externí odkaz:
https://doaj.org/article/d4f6fc9019ab406d8a0526a3377cc023
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Palliative Medicine Reports, Vol 3, Iss 1, Pp 169-180 (2022)
Background: More than 80% of the residents in German hospices suffer from tumor disease. But the administration of supportive-oncological therapies in hospices for symptom control is controversially discussed. Objectives: This study aims to investiga
Externí odkaz:
https://doaj.org/article/b908b7f02ad64b09824bb506afaf4108
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Biomolecules, Vol 13, Iss 6, p 902 (2023)
In humans, a total of 12 galectins have been identified. Their intracellular and extracellular biological functions are explored and discussed in this review. These galectins play important roles in controlling immune responses within the tumour micr
Externí odkaz:
https://doaj.org/article/c3aeaece05824133b386d0e2eec30373
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-10 (2021)
Abstract Background Cutaneous adverse drug reactions (CADR) associated with oncology therapy involve 45–100% of patients receiving kinase inhibitors. Such adverse reactions may include skin inflammation, infection, pruritus and dryness, symptoms th
Externí odkaz:
https://doaj.org/article/92101855f9264dff9ae6227bd4a8a7cc
Autor:
Fatemeh Asad Zadeh Vosta Kolaei, Beilei Cai, Hemanth Kanakamedala, Julia Kim, Vitalii Doban, Shiyu Zhang, Michael Shi
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
BackgroundMET exon 14 skipping mutation (METex14) is observed in ~3% of non-small cell lung cancer (NSCLC) cases and has been shown to be an independent poor prognostic factor associated with shorter overall disease-specific survival. Broad molecular
Externí odkaz:
https://doaj.org/article/bb644abbb2b74abea267314efd7c8d24